Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Exportin 1 (compound)
Most Correlated Studies
- Mouse embryonic fibroblasts (MEFs) depleted of Exportin-5
- Fibroblast IMR90 cells with ER-RAS G12V overexpression and XPO7 shRNA knockdown
- Oral epithelial cells from gingiva with TNFa induced inflammation treated with resolvin D1
- Glioblastoma A172 cells with ADAR1 and STAU1 siRNA knockdown
- Lung cancer A549 cells infected for 1hr with respiratory syncytial virus strain A2
Most Relevant Literature
- Safety of selinexor as the only exportin 1 (XPO1) inhibitor so far: a post-marketing study based on …
- Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's…
- C646 degrades Exportin-1 to modulate p300 chromatin occupancy and function.
- Differential impact of exportin-1-mediated nuclear export of RNAs on the RNA content of extracellula…
- Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors thr…
Most Relevant Clinical Trials
- A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
- Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Ca…
- Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
- Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
- Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma
